SuperworthSeaStar Medical EPS ICU
Diluted earnings per share by quarter and over the last twelve months, from 2021.
- Last 12 months, to Jun 30, 2025
- −$26.18
- Latest quarter, Q2 FY25
- −$1.80
- Fiscal year 2024
- −$77.58
SeaStar Medical's earnings per share was −$26.18 over the twelve months to Jun 30, 2025.
In its latest quarter, Q2 FY25, it was −$1.80.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2024 | −$77.58 | n/a |
| FY2023 | −$327.70 | n/a |
| FY2022 | −$320.00 | −2233% |
| FY2021 | $15.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY25 | −$1.80 | n/a | −$26.18 | |
| Q1 FY25 | −$4.40 | n/a | −$34.68 | |
| Q4 FY24 | −$8.98 | n/a | −$77.58 | |
| Q3 FY24 | −$11.00 | n/a | −$130.10 | |
| Q2 FY24 | −$10.30 | n/a | −$209.30 | |
| Q1 FY24 | −$47.30 | n/a | −$240.00 | |
| Q4 FY23 | −$61.50 | n/a | −$327.70 | |
| Q3 FY23 | −$90.20 | n/a | −$456.20 | |
| Q2 FY23 | −$41.00 | n/a | −$431.00 | |
| Q1 FY23 | −$135.00 | n/a | −$420.00 | |
| Q4 FY22 | −$190.00 | −7700% | −$320.00 | |
| Q3 FY22 | −$65.00 | −1400% | −$127.50 |
Against its peers
Companies in Medical - Instruments & Supplies nearest SeaStar Medical's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ICUSeaStar Medical | n/m | |
| NEPHNephros | $0.16 | +33% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| Peer median | $0.41 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on SeaStar Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.